Lab tests
|
Reference range
|
During first clinic visit
|
Repeated
|
---|
WBC (×103/μL)
|
4-11×103
|
5.63×103
| |
Hemoglobin (g/dL)
|
12-14
|
11.8
| |
MCV (fl)
|
86-96
|
64
| |
MCH (pg)
|
27-32
|
20
| |
Platelet (×103/μL)
|
150-450
|
315×103
| |
Ferritin (ng/mL)
|
13-150
|
24
| |
S.Iron (ug/dL)
|
37-145
|
140
| |
PT (seconds)
|
Control 13
|
27
| |
PTT (seconds)
|
Control 34
|
123.4
| |
INR (seconds)
|
0.8-1.2
|
2.7
| |
Urea (mg/dL)
|
15-38
|
29
| |
Creatinine (mg/dL)
|
0.6-1
|
1.04
| |
C3 (mg/dL)
|
80-152
|
142
| |
C4 (mg/dL)
|
14-40
|
28.6
| |
ANA titer
| |
1:320
| |
Anti-DNA
| |
Negative
| |
Anti-Sm EU/mL
|
Negative <20
|
24.4
| |
Positive >25
|
Anti-SSA(Ro) EU/mL
| |
Negative
| |
Anti-SSB(La) EU/mL
| |
Negative
| |
Anti-cardiolipin:
| | | |
(screening)
|
<20U/mL
|
281.75
|
388.9
|
IgG
| |
N/A
|
176.2
|
IgM
| |
N/A
| |
Anti-β2 GPI antibodies:
| | | |
IgG
|
<20U/mL
|
182.9
|
343.7
|
IgM
|
<20U/mL
|
N/A
|
N/A
|
Lupus anticoagulant
|
Not done (Patient on warfarin)
| | |
Protein C
|
Not done (Patient on warfarin)
| | |
Protein S
|
Not done (Patient on warfarin)
| | |
APC-resistance ratio
|
0.8-1.1
|
0.76
| |
Anti-thrombin Ш
|
75-120
|
88.6%
| |
- White blood cells (WBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), serum iron (s. iron), Prothrombin Time (PT), Partial Thromboplastin Time (PTT), International Normalized Ratio (INR), antinuclear antibody (ANA), antibodies to double-stranded (Anti-DNA), Antibody to the smith antigen (Anti-Sm), anti-Ro antibodies (Anti-SSA), anti-La antibodies (Anti-SSB), Immunoglobulin-G (IgG), Immunoglobulin M (IgM), activated protein C resistance ratio (APC-resistance ratio), not available in the laboratory (NA).